Invention Grant
- Patent Title: Hetarylaminonaphthyridines
- Patent Title (中): 杂芳基氨基萘啶
-
Application No.: US13580277Application Date: 2011-01-10
-
Publication No.: US08815893B2Publication Date: 2014-08-26
- Inventor: Alfred Jonczyk , Dieter Dorsch , Frank Zenke , Christiane Amendt
- Applicant: Alfred Jonczyk , Dieter Dorsch , Frank Zenke , Christiane Amendt
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP10001758 20100222
- International Application: PCT/EP2011/000054 WO 20110110
- International Announcement: WO2011/101069 WO 20110825
- Main IPC: C07D215/38
- IPC: C07D215/38 ; A61K31/04
Abstract:
Novel hetarylaminonaphthyridine derivatives of formula (I) wherein X, R1, R2, R3, R4, W1, W2, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.
Public/Granted literature
- US20120316166A1 HETARYLAMINONAPHTHYRIDINES Public/Granted day:2012-12-13
Information query
